Fresenius Kabi Austria GmbH
http://www.fresenius-kabi.com/de-at/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Fresenius Kabi Austria GmbH
BMS’ Cell Therapy For Lymphoma On Track For EU-Wide Approval
Several new drugs are now on track for an EU marketing authorization after getting the EMA’s thumbs up this week.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice